CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach.
Christian Peter MoritzYannick TholanceOda StoevesandtKarine FerraudJean-Philippe CamdessanchéJean-Christophe G AntoinePublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
The repertoire of targeted autoantigens of patients with CIDP differs in a systematic degree from those of controls. Systematic autoantigenomic approaches can help to understand the disease and to discover novel bioinformatical tools and novel autoantigen panels to improve diagnosis, treatment, prognosis, or patient stratification.
Keyphrases